Compare AVNW & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVNW | ARCT |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.9M | 293.9M |
| IPO Year | 2007 | 2019 |
| Metric | AVNW | ARCT |
|---|---|---|
| Price | $16.58 | $8.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | ★ $32.63 | $23.80 |
| AVG Volume (30 Days) | 165.4K | ★ 634.3K |
| Earning Date | 11-10-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.00 | 20.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $243,858,000.00 | $82,031,000.00 |
| Revenue This Year | $5.02 | N/A |
| Revenue Next Year | $6.04 | $8.84 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.56 | N/A |
| 52 Week Low | $13.92 | $5.50 |
| 52 Week High | $27.02 | $17.96 |
| Indicator | AVNW | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 38.66 | 37.23 |
| Support Level | $14.27 | $6.45 |
| Resistance Level | $20.66 | $8.69 |
| Average True Range (ATR) | 1.35 | 1.05 |
| MACD | -0.28 | -0.12 |
| Stochastic Oscillator | 15.23 | 6.48 |
Aviat Networks Inc manufacture and sell a range of wireless transport and access networking products, solutions and services to two principal customer types. Communications Service Providers (CSPs): These include mobile and fixed telecommunications network operators, broadband and internet service providers and network operators which generate revenues from the communications services. Private network operators: These are customers which do not resell communications services but build networks for reasons of economics, autonomy, and/or security to support a wide variety of mission critical performance applications. Examples include federal, state and local government agencies, transportation agencies, energy and utility companies, public safety agencies and broadcast network operators.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.